Navigation Links
Global Cancer Diagnostics Market to Witness Robust Growth, According to VPG Report Published at MarketPublishers.com
Date:9/27/2013

London, UK (PRWEB) September 27, 2013

At present, the world cancer diagnostics industry is on the threshold of technological breakthrough, supported by ongoing advancements in tumor diagnosis and therapy, introduction of new specific antigens and advances in research on cancer’s genetic basis. The world cancer diagnostics market is forecast to experience tremendous growth and rapid expansion in the next five years. Expected technological developments in the industry are likely to open many new opportunities in cancer diagnostics, enabling to determine genetic predispositions, detect specific tumors and monitor biological responses to cancer treatment. The rapid market expansion and growing demand for malignancy assays is expected to be spurred by the increase in the elderly population.

Abbott, Becton Dickinson, Epigenomics, Applied Gene Technologies, Panacea Pharmaceuticals, Myriad Genetics and Enzo Biochem are amid the leading companies which are currently active in the global cancer diagnostics market.

In-demand research report “Global Cancer Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies” worked out by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Cancer Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
Published: August, 2013
Pages: 1200
Price:    US$ 32,500.00
http://marketpublishers.com/report/diagnostics-diseases/cancer/global-cancer-diagnostics-market-2013-france-germany-italy-japan-spain-uk-usa-sales-forecasts-supplier-shares-competitive-strategies.html

The report provides an in-depth analysis of the cancer diagnostics market with a focus on France, Germany, Italy, Japan, Spain, the UK and the US. It discloses critical information on the market size and performance, delves into the competitive landscape, and uncovers details on the leading players in the field. The study presents a comprehensive market assessment by geography and tests; contains sales and market share analyses; examines the main trends in the sector. The research study evaluates the market opportunities, reviews potential market entry barriers and risks as well as suggests alternative business expansion strategies for suppliers, covers current and emerging products, analyzes potential applications of various diagnostic technologies. Moreover, the report includes sales forecasts for the major tumor markers.

Report Scope:

  •     Extensive overview of the worldwide cancer diagnostics market.
  •     In-depth analysis of seven country markets (France, Germany, Italy, Japan, Spain, the UK and the US).
  •     Review of the current and emerging products along with analysis of potential application of various diagnostic technologies.
  •     Discussion of the trends prevailing in the market.
  •     Essential data on the market size and structure.
  •     Examination of the competitive environment and comprehensive profiles of the leading companies.
  •     Discussion of the alternative market penetration strategies.
  •     Evaluation of the potential market entry barriers and risks.
  •     Alternative business expansion strategies for suppliers.
  •     Sales forecast for the major tumor markers.

More insightful research reports by the publisher can be found at VPG page.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11171596.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):